SBIR/STTR Research Award

Two-phase Production of an Organic Acid with CO2 Sequestration

Award identifier f33878040302d315126fa6f40d73a7ce92878fc94257d6a954609eebac221e18Awarding agency Department of Energy

Award amount

$150,000

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Energy
Branch
Not reported
Recipient company
Lygos, Inc.
Proposal award date
2018-07-02
Contract end date
2019-04-01
UEI
FR5ECFM6UKL6
Solicitation number
DE-FOA-0001771
Topic code
08b

Research abstract

Incumbent routes to myriad high-value chemicals require energy-intensive manufacturing practices that are hazardous to human health and the environment, and non-renewable petrochemical feedstocks. Existing plant biomass conversion technologies in biofuel and bioproduct manufacturing are largely inefficient, preventing industrial scale-up of drop-in replacements and deployment for mass consumption. Lygos, Inc. proposes to develop a microbial catalyst that converts 100% renewable plant sugars into a ubiquitous, high-value bioproduct via a highly efficient biosynthetic pathway, thereby significantly increasing the land’s effective product yield. (We cannot disclose the bioproduct due to the non- confidential nature of this summary.) Our proposed pathway further comprises CO2 sequestration, which increases theoretical yield of the bioproduct to >100%. We envision a bolt-on production facility co-located with cellulosic sugars and ethanol biofuel production. We anticipate upcycling waste CO2, thereby reducing industrial greenhouse gas emissions. Based on our techno-economic calculations, because the bio-product is more valuable than bio-ethanol, commercialization of the proposed technology in an integrated biorefinery can decrease biofuel production costs to 5% bioproduct yield from cellulosic glucose and CO2. In summary, we plan to generate strain libraries comprising enzymes that constitute the pathway, and engineer strains towards improved pathway activity and yield. With in-house capability to construct 200 unique strains per month, we are able to carry out the work plan in the Phase I time period. By leveraging previous successes in bringing bio-malonic acid to market, we believe that a 5% yield provides sufficient demonstration of technical feasibility to de-risk the pathway enzymes. We anticipate Phase I results to enable a Phase II work plan that includes manufacturing at a 100-liter scale with established partners such as the DOE-funded Advanced Biofuels Process Development Unit. If the project is successful, we anticipate bringing to market a drop-in bio- product with a green, cost-advantaged process in a global market estimated to exceed $400MM.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

11 SBIR/STTR records share this UEI (2011–2018). Reported award amounts total $4,048,213. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Agriculture, Department of Energy, National Science Foundation

Agency intelligence

Department of Energy

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.